Trial Profile
A Randomized, Open-label, Multiple-dose, Crossover Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic Drug-drug Interaction Between LGEV1801 and LGEV1802 in Healthy Korean Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary) ; Valsartan (Primary)
- Indications Essential hypertension; Heart failure; Hypercholesterolaemia; Hypertension; Postmyocardial infarction
- Focus Pharmacokinetics
- Sponsors LG Chem
- 13 Feb 2019 Status changed from not yet recruiting to completed.
- 24 May 2018 New trial record